From: Phase IV non-inferiority trials and additional claims of benefit
Additional benefit | N | Presentation of additional benefit | Conclusion on additional benefit | |||
---|---|---|---|---|---|---|
(N =22) | Â | Statistical test | Descriptively | Proven | Not proven | Not explicitly discussed |
Convenient method of administration | 1 | 0 | 0 | 0 | 0 | 1 |
Better safety profile | 12 | 5 | 7 | 7 | 3 | 2 |
Better compliance | 3 | 1 | 2 | 3 | 0 | 0 |
Less costly | 1 | 0 | 1 | 0 | 0 | 1 |
Convenient method of administration and better safety profile | 5 | 4 | 1 | 2 | 2 | 1 |